Ana P Gonzalez-Rodriguez
Overview
Explore the profile of Ana P Gonzalez-Rodriguez including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
337
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Lorenzo-Herrero S, Lopez-Soto A, Sordo-Bahamonde C, Gonzalez-Rodriguez A, Vitale M, Gonzalez S
Cancers (Basel)
. 2019 Jan;
11(1).
PMID: 30597841
Metastasis represents the leading cause of cancer-related death mainly owing to the limited efficacy of current anticancer therapies on advanced malignancies. Although immunotherapy is rendering promising results in the treatment...
12.
Redondo A, Valcarcel D, Gonzalez-Rodriguez A, Suarez-Lledo M, Bello J, Canales M, et al.
Br J Haematol
. 2018 Dec;
184(5):797-807.
PMID: 30548583
We conducted a phase 2 trial to evaluate the safety and efficacy of bendamustine instead of BCNU (carmustine) in the BEAM (BCNU, etoposide, cytarabine and melphalan) regimen (BendaEAM) as conditioning...
13.
Villa-Alvarez M, Lorenzo-Herrero S, Gonzalez-Rodriguez A, Lopez-Soto A, Payer A, Gonzalez-Garcia E, et al.
Oncoimmunology
. 2017 Nov;
6(10):e1353856.
PMID: 29123965
Chronic lymphocytic leukemia (CLL) is associated with a profound dysregulation of the immune system. Loss of T cell function is frequently caused in cancer by sustained signaling of inhibitory receptors....
14.
deAndres-Galiana E, Fernandez-Martinez J, Luaces O, Del Coz J, Huergo-Zapico L, Acebes-Huerta A, et al.
J Biomed Inform
. 2016 Mar;
60:342-51.
PMID: 26956213
Introduction: Chronic Lymphocytic Leukemia (CLL) is a disease with highly heterogeneous clinical course. A key goal is the prediction of patients with high risk of disease progression, which could benefit...
15.
Fernandez-Alvarez R, Gonzalez-Rodriguez A, Rubio-Castro A, Gonzalez M, Ramirez Payer A, Alonso-Garcia A, et al.
Leuk Lymphoma
. 2015 May;
57(2):463-466.
PMID: 25976108
No abstract available.
16.
Fernandez-Alvarez R, Gonzalez-Rodriguez A, Gonzalez M, Rubio-Castro A, Dominguez-Iglesias F, Solano J, et al.
Leuk Lymphoma
. 2015 Apr;
56(11):3096-102.
PMID: 25860241
Ferritin levels might correlate with disease activity in classical Hodgkin lymphoma (cHL). We analyzed the prognostic significance of the ferritin value at diagnosis in 173 cHL patients treated with ABVD...
17.
Huergo-Zapico L, Gonzalez-Rodriguez A, Contesti J, Gonzalez E, Lopez-Soto A, Fernandez-Guizan A, et al.
Cancer Immunol Immunother
. 2012 Jan;
61(8):1201-10.
PMID: 22215138
MICA is a ligand of the activating receptor NKG2D, expressed by NK and T cells. MICA expression is induced in cancer cells favoring their elimination by the immune system; however,...
18.
Gonzalez-Rodriguez A, Contesti J, Huergo-Zapico L, Lopez-Soto A, Fernandez-Guizan A, Acebes-Huerta A, et al.
Leuk Lymphoma
. 2010 Sep;
51(10):1829-36.
PMID: 20846097
The prognostic value of the number of T cells and NK cells at diagnosis in CLL was analyzed in a cohort of 256 patients with CLL diagnosed between 1997 and...